Menarini Biotech
Salvatore Montemagno is a skilled specialist in upstream processes with extensive experience in biotechnology. Currently serving as a USP upstream process specialist at Menarini Biotech since April 2013, Salvatore focuses on process improvement, technological development, process scale-up/scale-down, and technology transfer. Prior experience includes a role as a Manufacturing Technician at Novartis Vaccines, where Salvatore contributed to the production of vaccines against Neisseria Meningitidis group B, specifically with cultivation processes in large-scale bioreactors. An R&D internship at Università degli Studi di Palermo involved research on colorectal cancer, while a trainee position for a master's thesis at the University of Applied Sciences and Arts Northwestern Switzerland FHNW centered on proteomic analysis of muscle cells related to muscular dystrophy. Salvatore holds a Master's degree in industrial biotechnology from Università degli Studi di Palermo.
This person is not in the org chart
This person is not in any offices
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.